Insider Transactions in Q1 2023 at Horizon Therapeutics Public LTD CO (HZNP)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 13
2023
|
Elizabeth H.Z. Thompson EVP, Research & Development |
SELL
Bona fide gift
|
Direct |
2,000
-12.07%
|
-
|
|
Mar 02
2023
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
4,372
+1.69%
|
$69,952
$16.06 P/Share
|
|
Mar 01
2023
|
Sean M. Clayton EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
7,032
-48.81%
|
$773,520
$110.34 P/Share
|
|
Mar 01
2023
|
Sean M. Clayton EVP, General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
14,129
+49.51%
|
-
|
|
Jan 17
2023
|
Andy Pasternak EVP, Chief Strategy Officer |
SELL
Open market or private sale
|
Direct |
27,129
-32.5%
|
$3,065,577
$113.03 P/Share
|
|
Jan 17
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Bona fide gift
|
Indirect |
33,795
+28.91%
|
-
|
|
Jan 17
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Bona fide gift
|
Direct |
33,795
-93.43%
|
-
|
|
Jan 13
2023
|
Aaron Cox EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
36,148
-99.24%
|
$4,084,724
$113.17 P/Share
|
|
Jan 11
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,368
-8.52%
|
$380,584
$113.1 P/Share
|
|
Jan 10
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,368
-7.85%
|
$380,584
$113.05 P/Share
|
|
Jan 06
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Indirect |
5,187
-9.52%
|
$586,131
$113.29 P/Share
|
|
Jan 05
2023
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
26,901
-18.04%
|
$3,039,813
$113.24 P/Share
|
|
Jan 05
2023
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
54,253
+26.68%
|
-
|
|
Jan 05
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
22,655
-34.56%
|
$2,560,015
$113.24 P/Share
|
|
Jan 05
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
51,132
+43.82%
|
-
|
|
Jan 05
2023
|
Patrick Mc Ilvenny Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,147
-39.63%
|
$468,611
$113.24 P/Share
|
|
Jan 05
2023
|
Patrick Mc Ilvenny Chief Accounting Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,973
+43.25%
|
-
|
|
Jan 05
2023
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
97,461
-13.65%
|
$11,013,093
$113.24 P/Share
|
|
Jan 05
2023
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
219,995
+23.56%
|
-
|
|
Jan 01
2023
|
Timothy P Walbert Chairman, President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
46,365
-8.58%
|
$5,239,245
$113.8 P/Share
|
|
Jan 01
2023
|
Timothy P Walbert Chairman, President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
104,498
+16.21%
|
-
|
|
Jan 01
2023
|
Michael A. Des Jardin EVP, Technical Operations |
SELL
Payment of exercise price or tax liability
|
Direct |
9,561
-9.16%
|
$1,080,393
$113.8 P/Share
|
|
Jan 01
2023
|
Michael A. Des Jardin EVP, Technical Operations |
BUY
Exercise of conversion of derivative security
|
Direct |
21,772
+17.26%
|
-
|
|
Jan 01
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
9,717
-40.24%
|
$1,098,021
$113.8 P/Share
|
|
Jan 01
2023
|
Jeffrey W Sherman EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
21,772
+47.41%
|
-
|